140 related articles for article (PubMed ID: 18343563)
1. Editorial comment on: Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Zigeuner R
Eur Urol; 2008 Oct; 54(4):873-4. PubMed ID: 18343563
[No Abstract] [Full Text] [Related]
2. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Pinthus JH; Kleinmann N; Tisdale B; Chatterjee S; Lu JP; Gillis A; Hamlet T; Singh G; Farrokhyar F; Kapoor A
Eur Urol; 2008 Oct; 54(4):866-73. PubMed ID: 18343565
[TBL] [Abstract][Full Text] [Related]
3. Re: Jehonathan H. Pinthus, Nir Kleinmann, Britton Tisdale, et al. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol 2008;54:866-74.
Kapoor S
Eur Urol; 2009 Mar; 55(3):e52-3. PubMed ID: 18789573
[No Abstract] [Full Text] [Related]
4. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment on: Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Novara G
Eur Urol; 2009 May; 55(5):1153-4. PubMed ID: 18930580
[No Abstract] [Full Text] [Related]
6. Editorial comment.
Campbell SC; Lane BR
J Urol; 2010 Feb; 183(2):485; discussion 485. PubMed ID: 20006871
[No Abstract] [Full Text] [Related]
7. Re: "vaginal metastasis and thrombocytopenia from renal cell carcinoma: a case report".
Weiss B
Gynecol Oncol; 2005 Jan; 96(1):263-4; author reply 264-5. PubMed ID: 15589615
[No Abstract] [Full Text] [Related]
8. Editorial comment.
McDougal WS
J Urol; 2009 Oct; 182(4):1293; discussion 1293. PubMed ID: 19683301
[No Abstract] [Full Text] [Related]
9. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
[TBL] [Abstract][Full Text] [Related]
10. Editorial comment.
Haas GP
Urology; 2010 Feb; 75(2):270. PubMed ID: 20152476
[No Abstract] [Full Text] [Related]
11. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
[TBL] [Abstract][Full Text] [Related]
12. Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
Pantuck AJ
Eur Urol; 2007 Oct; 52(4):1145-6. PubMed ID: 17336450
[No Abstract] [Full Text] [Related]
13. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment on: Prognosis value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Russo P
Eur Urol; 2009 Feb; 55(2):459. PubMed ID: 18692952
[No Abstract] [Full Text] [Related]
15. Editorial comment.
Campbell SC; Rini BI
J Urol; 2009 Dec; 182(6):2599-600. PubMed ID: 19836760
[No Abstract] [Full Text] [Related]
16. The behavior of renal cell carcinoma: sex, lies and tumor size.
Marshall FF
J Urol; 2008 May; 179(5):1657. PubMed ID: 18343448
[No Abstract] [Full Text] [Related]
17. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
18. Editorial comment on: update on the medical treatment of metastatic renal cell carcinoma.
Ficarra V; Novara G
Eur Urol; 2008 Aug; 54(2):324-5. PubMed ID: 18485580
[No Abstract] [Full Text] [Related]
19. Editorial comment on: update on the medical treatment of metastatic renal cell carcinoma.
Van Poppel H
Eur Urol; 2008 Aug; 54(2):324. PubMed ID: 18485572
[No Abstract] [Full Text] [Related]
20. Contralateral adrenal metastasis from renal cell carcinoma.
Huang JG; O'Malley PJ; Khaira HS; Costello AJ
ANZ J Surg; 2007 Aug; 77(8):705-6. PubMed ID: 17635292
[No Abstract] [Full Text] [Related]
[Next] [New Search]
